Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EBITDA (2024 - 2025)

Historic EBITDA for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$14.0 million.

  • Beta Bionics' EBITDA fell 4501.4% to -$14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.5 million, marking a year-over-year change of. This contributed to the annual value of -$54.8 million for FY2024, which is 2471.68% down from last year.
  • Beta Bionics' EBITDA amounted to -$14.0 million in Q3 2025, which was down 4501.4% from -$17.0 million recorded in Q2 2025.
  • Beta Bionics' EBITDA's 5-year high stood at -$9.7 million during Q3 2024, with a 5-year trough of -$28.5 million in Q1 2025.